An Important Pilot Study for the Vaccine was Finished in 2018
February 22, 2019 An Important Pilot Study for the Vaccine was Finished in 2018 TALLAHASSEE, Fla. – February 22, 2019- Global Green, Inc., a green bio-pharmaceutical Company provides the following information: Salmogenics, Proof of Concept and Efficacy Study of a Salmonella vaccine in combination with a Marek’s vaccine against a Salmonella challenge. Salmogenics vaccine stimulates an immune response in inoculated […]Read More »The Company filed Form 8-K in December 2015
The Company filed Form 8-K in December 2015 http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=11086364Read More »
Global Green Announces Update on Appeal Filed Concerning Trading of Stock
Global Green, Inc. Files Petition to Appeal the SEC’s Suspension of Trading
Global Green, Inc. Hires Law Firm to Handle Petition to be Filed with SEC
Global Green Announces Expiration of Merial Agreement
Global Green Responds to SEC Action
Global Green Cites Research Finding Salmonella Detection Continues to Fail
Global Green, Inc. Cites Industry Studies on Airborne Transmission of Salmonella
Global Green, Inc. Announces Extension of Agreement with Merial for Evaluation of Salmonella Vaccine and License Option
Global Green, Inc. Cites Studies Indicating Salmonella is Possible to Eradicate
Global Green Inc.’s Salmonella Vaccine Meets FDA Food Policy of Phasing Out Antibiotics on Farms
Global Green, Inc. to Proceed with Plans to Construct a Manufacturing Facility
Global Green, Inc.’s Salmonella Vaccine Could Meet the Eight Point Ideal Vaccine Criteria
Global Green, Inc. Poultry Vaccine for Salmonella to Offer Chemical-Free Solution
Global Green, Inc. Signs Agreement with Merial for Evaluation of Salmonella Vaccine and License Option
Global Green’s Salmonella Vaccine Could Contribute to Sustainable Long-term Poultry Health and Performance
Studies Reaffirm Global Green’s Poultry Vaccine Meets Need of Preventive Method Against Salmonella at the Farm Level
Global Green’s Chief Scientist and VP – R&D to be Keynote Speaker at Texas A&M University System’s Scientific Event
Global Green’s Salmonella Vaccine Produces No Stress in Poultry and Strengthens Immune System
Global Green, Inc. Announces Trial Studies Indicate Use of Salmogenics May Improve Performance of Broilers
Global Green, Inc. Initiates Advanced Trial in Quest of Salmonella-Free Egg
Global Green, Inc. Focused on $5.4 Billion Veterinary Vaccine Market
Global Green, Inc. Invited to Present at 2012 World Animal Health Congress
Global Green, Inc. Cites Recent Industry Studies that Reinforce Significance of Its’ Salmonella Vaccine, Salmogenics
Global Green, Inc. Announces Conclusion of Final Study Conducted for USDA Approval of Salmonella Vaccine
Global Green, Inc. Launches New Website
Press Releases
Global Green > Press Releases